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Gestational diabetes, comparison of  
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trimester of pregnancy with non GDM 
women: Analysis of a cohort study
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ABSTRACT
Pregnant women are normally screened for Gestational diabetes (GDM) at week 
24 of pregnancy. However some women develop the disease later on their pregnancies. 
No study has analyzed women developing GDM later in pregnancy. Objective: To 
analyze data on a cohort study and compare women diagnosed with GDM in second 
and third trimester of pregnancy with women without GDM. Results: GDM women 
diagnosed during their first two trimesters of pregnancy were older (p = 0.0008) and 
had higher body mass index (BMI) (p = 0.0007) than non GDM women. However, 
the only risk factor in women diagnosed in their third trimester of pregnancy was 
having first degree relatives with type 2 DM and this was independent of age and 
BMI (OR of 2.7, 95% CI 1.2 - 6.0). Conclusions: Women who develop GDM in 
their second trimester of pregnancy have known risk factors for diabetes mellitus 
such as age and higher BMI, however, the only recognised risk factor between non 
GDM women and women developing GDM late in pregnancy is family history of 
type 2 DM.  Two populations of GDM may exist and future studies should focus on 
analysing short and long term complications of these women to support the need to 
diagnosed and treat them all.
(Rev Med Chile 2010; 138: 316-321).
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Diabetes gestational, comparación entre mujeres 
diagnosticadas en el segundo y tercer trimestre 
del embarazo con mujeres sin diabetes  
gestacional: Análisis de un estudio de cohorte
La pesquisa para diabetes gestacional (DG) se realiza normalmente en la se-
mana 24 de embarazo. Sin embargo, muchas mujeres desarrollan la enfermedad 
más tardíamente durante el embarazo. No hay estudios analizando DG en tercer 
trimestre del embarazo. Objetivo: Analizar los datos de una cohorte para comparar 
mujeres con DG diagnosticada en segundo y tercer trimestre del embarazo con mu-
jeres sin DG. Resultados: Las mujeres diagnosticadas en los primeros dos trimestres 
del embarazo eran mayores (p = 0,0008) y tenían mayor índice de masa corporal 
(IMC) (p = 0,0007) que las mujeres sin DG. El único factor de riesgo en mujeres 
diagnosticadas en el tercer trimestre del embarazo fue tener antecedentes familiares 
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de DM, lo cual fue independiente de la edad e IMC (OR: 2,7, 95% CI 1,2 - 6,0). 
Conclusiones: Mujeres con DG diagnosticada en el segundo trimestre del embarazo 
tienen distintos factores de riesgo que mujeres diagnosticadas más tardíamente. Es 
posible que existan dos poblaciones de DG según el período de diagnóstico, por lo que 
debiera estudiarse si las complicaciones de estos dos subgrupos justifican el diagnóstico 
y tratamiento de ambos.
The diagnosis of gestational diabetes mellitus (GDM) has been proved to be critical when treating conditions associated to adverse 
consequences to mother and child. In this regard 
GDM has been associated with a greater risk of 
hypertension and Caesarean section and abortion1. 
Newborns from GDM mothers have a higher inci�
dence of being large for gestational age (macroso�
mia)2,4, being born preterm4, of hypoglicaemia and 
jaundice3,6, of admission to a neonatal unit3 and 
perinatal death2,5. GDM has also been associated 
with long term complications in the mother and 
in the child. Mothers with previous GDM have 
higher incidence of type 2 diabetes mellitus7 while 
their children have higher risk of developing adult 
obesity and other chronic non�transmissible disea�
ses8. However, not all the studies on GDM support 
these associations and the discrepancies could be 
explained by the different methods to diagnose 
GDM. In this regard, some studies use 75 g�1h 
OGTT while others use 100 g�2h OGTT, some 
centres use 200 mg/dl cut�off to diagnose GDM9 
while others agree with the WHO recommenda�
tions of a 140 mg/dl cut�off10. Moreover, some 
centres test al women while others test only women 
with recognised risk factors, and some centres test 
only in second trimester o pregnancy while others 
retest during the third trimester. These differences 
in the approach to diagnosing GDM explain not 
only part of the different prevalences in GDM but 
also variability in short� and long�term risk asso�
ciated with GDM. Lowering the cut�off glycaemia 
or testing more frequently or later in pregnancy 
would result in both, higher prevalence of GDM 
but lower risk associated with the diagnosis. To 
our knowledge there are no studies comparing 
GDM women diagnosed in second and in third 
trimester of pregnancy with women who do not 
develop GDM. This comparison would help to 
know if these women share the same risk factors 
and would enlighten us regarding the benefit of 
testing all women in late pregnancy. The primary 
objective of this study was to compare women 
diagnosed with GDM in second with those diag�
nosed in third trimester of pregnancy in terms 
of recognised risk factors for GDM. Secondary 
objectives were to compare risk factors and deli�
very outcome between GDM in second and third 
trimester of pregnancy with non�GDM women. 
Research designs and Methods
Women who belonged to a cohort of pregnant 
women who attended antenatal care at two poly�
clinics associated to Catholic University Hospital, 
Santiago, Chile, were followed from January 2002 
to June 2003. All pregnant women who attended 
to antenatal care before week 20 of a single foetus 
were enrolled into the study after signing informed 
consent. Women were dated between weeks 24 to 
28 and between week 34 to 36 of pregnancy for 
anthropometric measurements and blood tests. 
Follow up was completed in 50 women who 
developed GDM in the first two trimesters of 
pregnancy and 27 women diagnosed with GDM 
in the third trimester of pregnancy, along with 327 
non�GDM women (70% of the initial cohort). 
Gestational Diabetes was diagnosed or ruled out 
according to the classification of the Chilean Mi�
nisterial Norms based on the American Diabetes 
Association11 plus a second oral glucose tolerance 
test (OGTT) made to all women during the third 
trimester of pregnancy to completely rule out the 
development of diabetes. While data on pregnancy 
were prospectively recorded, delivery data were 
extracted from the clinical records. Women in the 
study attended to routine obstetric appointments 
and the obstetricians were aware of the study and 
had access to the GDM diagnosis.  
To study recognised risk factors for GDM, we 
analyzed age, pre�pregnancy weight according to 
mother’s report at recruitment, educational level, 
marital status, number of previous pregnancies, 
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antecedents in previous pregnancies including 
abortion, stillbirth, macrosomia, intra uterine 
growth retardation (IUGR) and congenital mal�
formations. We also analyzed weight, height, 
fasting glycaemia and insulinaemia, insulin resis�
tance calculated through Homeostasis Modelling 
Assessment (HOMA), all measured at recruitment 
in all the mothers. Weight and height were mea�
sure by the same nutritionist with the patient in 
underwear in an electronic SECA balance with 
height rod. Glycaemia was measured through 
glucose oxidase method while insulinaemia was 
measured through radioimmunoassay technique. 
HOMA values of 2.5 or over were considered as 
insulin resistance. To analyze complications as�
sociated to GDM we measured gestational age 
at delivery, type of delivery, weight and height of 
the newborn, Apgar score of the newborn and 
presence of metabolic and trauma complications 
in the newborn and/or the mother. 
In the statistical analysis variables are presented 
as percentages if they are categorical or means 
and standard deviation (mean ± SD) if they are 
continuous. To show the precision of the data 
standard error (SE) or 95% confidence interval 
are presented. Association of recognised risk fac�
tors for GDM and characteristics on delivery with 
GDM were analyzed with Chi Squared, ANOVA 
and Student T Test as appropriate. We analyzed 
general data on the whole cohort, followed by the 
analysis of differences on risk factors and delivery 
data between non�GDM and GDM groups and 
separately for non�GDM with each group of GDM 
women diagnosed in second and third trimester of 
pregnancy. It was not necessary to transform vari�
ables since all of them were normally distributed. 
Independence of associated variables was tested 
with logistic regression using stepwise analysis. 
Statistical analyzes were performed using STATA 
9.0 Software.
Ethical approval from Catholic University of 
Chile and London School of Hygiene and Tropical 
Medicine were obtained. 
Results
The cohort consisted in women 16 to 44 years 
old with a mean of 30.8 ± 5.0 years. Characteristics 
of the two groups of GDM and non�GDM women 
are shown in Table 1. 
The comparison between non�GDM women 
rev Med chile 2010; 138: 316-321
gestational diabetes, diagnosed in second and third trimester of pregnancy - A. Huidobro et a
Table 1. Characteristics of GDM women diagnosed during the second trimester of pregnancy,  
women diagnosed in third trimester of pregnancy and non-GDM women
Variable GDM1 
(n = 50)
GDM2 
(n = 27)
Non-GDM 
(n = 327)
educational status
iliterate % (n) 0 0 0.31 (1)
First school (%) (n) 42 (21)* 22.2 (6) 24.8 (81)
High school (%) (n) 58.0 (29)* 77.8 (21) 74.9 (245)
Age  (years) 33 (31.5 - 34.5)† 31 (29.0 - 33.0) 30.5 (29.9 - 31.0)
BMi0  (kg/m
2) 26.6 (24.9 - 28.3)* 25.3 (23.7 - 26.9) 25.1 (24.6 - 25.5)
BMi1  (kg /m
2) 28.6 (27.4 - 29.7)† 26.8 (25.2 - 28.4) 26.6 (26.2 - 27.0)
nº Previous pregnancies 1.5 (1.0 - 2.0)† 1.1 (0.4 - 1.8) 0.95 (0.8 - 1.1)
PiH or colestasis in previous pregnancy % (n) 32.7 (16) 25.9 (7) 24.2 (79)
Abortion (n) 0.5 (0.1 - 0.8) 0.5 (0.0 - 1.1) 0.3 (0.2 - 0.4)
gycaemia (mg/dl) 82.9   (79.5 - 86.2)† 78.6 (75.8 - 81.4) 76.5 (75.6 - 77.5)
HoMA 3.4 (0.9 - 6.0)† 1.6 (1.4 - 1.8) 1.7 (1.6 - 1.8)
*p < 0.05 when comparing with non-gdM. †p < 0.01 when comparing with non-gdM. BMi0:
 Pre-pregnancy body mass index. 
BMi1:
 Body mass index at recruitment. PiH: Pregnancy induced hypertension. gdM1:
 gestational diabetes diagnosed at second 
trimester of pregnancy. gdM2:
 gestational diabetes diagnosed at third trimester of pregnancy.
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Table 2. Characteristics of mothers and their deliveries comparing those who developed GDM  
in the second trimester of pregnancy, those diagnosed in their third trimester of pregnancy  
and those who did not develop GDM
GDM1 GDM2 Non-GDM
Weight gain(kg)
Mean (95% ci)
9.6 
(6.9 - 12.3)†
12.7 
(11.0 - 14.4)
12.4 
(11.9 - 12.9)
gestational Age (weeks)
Mean (95% ci)
37.7 
(37.0 - 38.4)†
38.2 
(37.5 - 38.8)
38.7 
(38.6 - 38.9)
newborn weight (g)
Mean (95% ci)
3235 
(3019 - 3451)
3381.2 
(3149 - 3613)
3334.4 
(3281 - 3388)
newborn height (cm)
Mean (95% ci)
48.9 
(47.9 - 49.8)
50.0 
(49.0 - 51.0)
49.4 
(49.2 - 49.7)
complications of the newborn 22.9% 28% 17.6%
†p < 0.01 when comparing with non-gdM. gdM1: gestational diabetes diagnosed at second trimester of pregnancy. 
gdM2: gestational diabetes diagnosed at third trimester of pregnancy.
and GDM women diagnosed in second trimester 
of pregnancy showed significant differences in 
education, age, BMI, basal glycaemia and HOMA. 
GDM women diagnosed in second trimester of 
pregnancy were less educated (p = 0.036), older 
(p = 0.0008), had more previous pregnancies 
(p = 0.004) and had a higher body mass index 
(BMI) in the pre�pregnancy stage (p = 0.028) 
and in their first antenatal control (p = 0.0007) 
than non�GDM women. The number of previous 
pregnancies was no longer different after adjusting 
by maternal age (p = 0.15). BMI at pre�pregnancy 
state and at recruitment were no longer different 
between GDM at second trimester of pregnancy 
and non�GDM women after adjusting by age 
in logistic regression (p = 0.08). In the stepwise 
logistic regression only age and glycaemia at 
recruitment were independent predictors of de�
veloping GDM in second trimester of pregnancy. 
The only significant difference between women 
diagnosed with GDM in their third trimester of 
pregnancy and non�GDM women was that the 
formers had a higher percentage of family history 
of type 2 DM (44.4% vs 22.6%, p = 0.04) and this 
was independent from age and BMI with an OR 
of 2.7 (95% CI 1.2 � 6.0). 
Regarding outcomes at delivery, no signifi�
cant differences were found among the groups 
in birth weight or height. Newborns from GDM 
mothers had more complications than babies 
from non�GDM mothers, but this difference was 
not statistically significant. Delivery outcomes are 
shown in Table 2. Women diagnosed with GDM in 
second trimester of pregnancy gained less weight 
than non�GDM women (p = 0.0026) and had 
smaller gestational age than non�GDM women 
(p = 0.0001). The association between weight gain 
and GDM development in the second trimester 
of pregnancy was independent of maternal age, 
BMI, glycaemia, insulinaemia and HOMA at re�
cruitment (p = 0.026). No difference was found 
between GDM women diagnosed during third 
trimester of pregnancy and non�GDM women re�
garding delivery outcomes. Although these women 
presented more complications than GDM women 
diagnosed earlier and with non�GDM women, this 
difference was not significant. 
Discussion
In this analysis of a cohort of women followed 
to diagnose GDM we found that those GDM 
women diagnosed during the third trimester of 
pregnancy have different risk factors than women 
diagnosed earlier in pregnancy. In this study, wom�
en diagnosed in second trimester are older than 
non�GDM women, present a higher BMI previous 
to pregnancy and in their first antenatal visit and 
have higher fasting glycaemia, higher insulinaemia 
and higher insulin resistance measured through 
HOMA. Age, weight and glycaemia are known 
risk factors for GDM12 and they could explain 
GDM development early in pregnancy. However 
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in this cohort, 35% of GDM women developed 
this disease in their third trimester of pregnancy 
and they did not differ in recognised risk factors 
from non�GDM women. The lack of recognised 
risk factors could mean that these women have 
unknown risk factors that are probably not as 
strong as the known ones. This could also explain 
why these women manifest GDM in later stages of 
pregnancy. Other possibility is that these women 
are developing a physiologically different GDM. 
These women were not as insulin resistant early in 
pregnancy as the ones that develop GDM in second 
trimester of pregnancy. Therefore, they could be 
developing diabetes with predominance in beta 
cell failure over insulin resistance, resembling 
type 1 DM. However, it is remarkable that these 
women are more likely to have a family history of 
type 2 DM. The relationship between family his�
tory of type 2 DM and GDM has been described 
in a large cohort of Sardinian women in whom 
GDM could not be predicted by recognised risk 
factors13. This relationship has also been shown 
in a cross sectional study in 1414 GDM women 
and 1011 controls in which the  highest associa�
tions were with prior GDM and family history 
of Type 2 DM14. In contrast, a study on 90 GDM 
women with family history of type 2 DM and 
83 women without family history of type 2 DM 
showed that recognised risk factors predict better 
GDM in women with family history of type 2 
DM15. A recent study that compares women with 
GDM diagnosed in the second trimester, GDM 
diagnosed in the third trimester and non�GDM 
women did not found differences among the three 
groups, except that GDM women diagnosed later 
in pregnancy had higher BMI (16). However, this 
study analyzed only women at high risk for GDM 
with a prevalence of GDM of 72% and is therefore 
not comparable to our study. The smaller weight 
gain in women who developed GDM earlier in 
pregnancy could be explained by the fact that they 
were at high risk for GDM and diet to diminish 
that risk. 
On the other hand, characteristics on delivery 
were not different between GDM women diag�
nosed late in pregnancy and non�GDM women, 
while GDM women diagnosed in second trimester 
of pregnancy delivered earlier their babies. This 
could be explained by different criteria used by 
the gynaecologist at the moment of planning the 
deliveries, since they were aware of the GDM con�
dition of women diagnosed earlier. Other studies 
demonstrate that complications are not higher 
in GDM when women are treated intensively for 
their disease16. One of the factors that justify the 
diagnosis of GDM is the risk to the child and in 
this cohort we could not demonstrate this risk, 
probably because of the limited number of GDM 
women.
Conclusion
GDM women diagnosed in second trimester of 
pregnancy are older and have higher fasting gly�
caemia and insulinaemia than women diagnosed 
with GDM in their third trimester of pregnancy. 
Women diagnosed later in pregnancy are not 
different from non�GDM women, but have more 
family history of type 2 DM. Larger studies should 
analyze these apparently two different populations 
of GDM women to estimate the costs and benefits 
of diagnosing GDM in late pregnancy.  
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